TY - JOUR
T1 - Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan
AU - Hatta, Waku
AU - Gotoda, Takuji
AU - Oyama, Tsuneo
AU - Kawata, Noboru
AU - Takahashi, Akiko
AU - Yoshifuku, Yoshikazu
AU - Hoteya, Shu
AU - Nakamura, Koki
AU - Hirano, Masaaki
AU - Esaki, Mitsuru
AU - Matsuda, Mitsuru
AU - Ohnita, Ken
AU - Shimoda, Ryo
AU - Yoshida, Motoyuki
AU - Dohi, Osamu
AU - Takada, Jun
AU - Tanaka, Keiko
AU - Yamada, Shinya
AU - Tsuji, Tsuyotoshi
AU - Ito, Hirotaka
AU - Hayashi, Yoshiaki
AU - Nakamura, Tomohiro
AU - Shimosegawa, Tooru
N1 - Publisher Copyright:
© 2016, Japanese Society of Gastroenterology.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Background: Although radical surgery is routinely performed for patients who do not meet the curative criteria for endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) due to the risk of lymph node metastasis (LNM), this standard therapeutic option may be excessive given the lower number of patients with LNM. Therefore, we aimed to investigate long-term outcomes and validate risk factors predicting recurrence after ESD. Methods: Of 15,785 patients who underwent ESD for EGC at 19 institutions between 2000 and 2011, 1969 patients not meeting the curative criteria were included in this multi-center study. Based on the treatment strategy after ESD, patients were divided into radical surgery (n = 1064) and follow-up (no additional treatment, n = 905) groups. Results: Overall survival (OS) and disease-specific survival (DSS) were significantly higher in the radical surgery group than in the follow-up group (p < 0.001 and p = 0.012, respectively). However, the difference in 3-year DSS between the groups (99.4 vs. 98.7 %) was rather small compared with the difference in 3-year OS (96.7 vs. 84.0 %). LNM was found in 89 patients (8.4 %) in the radical surgery group. Lymphatic invasion was found to be an independent risk factor for recurrence in the follow-up group (hazard ratio 5.23; 95 % confidence interval 2.01–13.6; p = 0.001). Conclusions: This multi-center study, representing the largest cohort to date, revealed a large discrepancy between OS and DSS in the two groups. Since follow-up with no additional treatment after ESD may be an acceptable option for patients at low risk, further risk stratification is needed for appropriate individualized treatment strategies.
AB - Background: Although radical surgery is routinely performed for patients who do not meet the curative criteria for endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) due to the risk of lymph node metastasis (LNM), this standard therapeutic option may be excessive given the lower number of patients with LNM. Therefore, we aimed to investigate long-term outcomes and validate risk factors predicting recurrence after ESD. Methods: Of 15,785 patients who underwent ESD for EGC at 19 institutions between 2000 and 2011, 1969 patients not meeting the curative criteria were included in this multi-center study. Based on the treatment strategy after ESD, patients were divided into radical surgery (n = 1064) and follow-up (no additional treatment, n = 905) groups. Results: Overall survival (OS) and disease-specific survival (DSS) were significantly higher in the radical surgery group than in the follow-up group (p < 0.001 and p = 0.012, respectively). However, the difference in 3-year DSS between the groups (99.4 vs. 98.7 %) was rather small compared with the difference in 3-year OS (96.7 vs. 84.0 %). LNM was found in 89 patients (8.4 %) in the radical surgery group. Lymphatic invasion was found to be an independent risk factor for recurrence in the follow-up group (hazard ratio 5.23; 95 % confidence interval 2.01–13.6; p = 0.001). Conclusions: This multi-center study, representing the largest cohort to date, revealed a large discrepancy between OS and DSS in the two groups. Since follow-up with no additional treatment after ESD may be an acceptable option for patients at low risk, further risk stratification is needed for appropriate individualized treatment strategies.
KW - Early gastric cancer
KW - Endoscopic submucosal dissection
KW - Follow-up
KW - Lymphatic invasion
KW - Radical surgery
UR - http://www.scopus.com/inward/record.url?scp=84964370053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964370053&partnerID=8YFLogxK
U2 - 10.1007/s00535-016-1210-4
DO - 10.1007/s00535-016-1210-4
M3 - Article
C2 - 27098174
AN - SCOPUS:84964370053
SN - 0944-1174
VL - 52
SP - 175
EP - 184
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 2
ER -